WilliamRamsesBishaiMD
Infectious Disease • Baltimore, MDProfessor of Medicine, Professor of Molecular Biology and Genetics, Joint of Pathology, Johns Hopkins University School of Medicine
Are you Dr. Bishai?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 52 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1800 Orleans Street
Baltimore, MD 21287
Summary
- Dr. William Bishai, MD is an infectious disease specialist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland. He is affiliated with Johns Hopkins Hospital and is a Professor of Medicine at Joint of Pathology.
Education & Training
Brigham and Women's HospitalResidency, Internal Medicine, 1989 - 1991
Harvard Medical SchoolClass of 1989
Certifications & Licensure
MD State Medical License 1991 - 2026
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2002
- Investigator Howard Hughes Medical Institute
Publications & Presentations
PubMed
- 20 citationsMethod to integrate multiple plasmids into the mycobacterial chromosomeBeatrice Saviola, William R. Bishai
Nucleic Acids Research. 2004-01-16 - 128 citationsA Novel Copper-Responsive Regulon in Mycobacterium tuberculosisRichard A. Festa, Marcus B. Jones, Susan M. Butler-Wu, Daniel Sinsimer, Russell Gerads
Molecular Microbiology. 2011-01-01 - 388 citationsDiagnostic point-of-care tests in resource-limited settingsPaul K. Drain, Emily P. Hyle, Farzad Noubary, Kenneth A. Freedberg, Douglas Wilson
The Lancet. Infectious Diseases. 2014-03-01
Press Mentions
Omicron Linked to Rise in Croup in Babies; TB Vaccine Improves Immune Response to CoronavirusMarch 16th, 2022- COVID SCIENCE-Omicron Linked to Rise in Croup in Babies; TB Vaccine Improves Immune Response to CoronavirusMarch 16th, 2022
- Omicron Linked to Increased Croup in Babies; Tuberculosis Vaccine Improves Immune Response to CoronavirusMarch 16th, 2022
- Join now to see all
Grant Support
- Biomarkers And Signaling In TuberculosisNational Institute Of Allergy And Infectious Diseases2011
- Screen For Synthetic Lethality In Mycobacterium TuberculosisNational Institute Of Mental Health2010–2011
- M.Tb Survival Regulatory GenesNational Institute Of Allergy And Infectious Diseases2010–2011
- Gene Regulation And Virulence In TBNational Institute Of Allergy And Infectious Diseases2010–2011
- PK/PD Evaluation Resistance Development In Caseating GranulomaNational Institute Of Allergy And Infectious Diseases2008–2011
- Gene Regulation And Virulence In TB And MACNational Institute Of Allergy And Infectious Diseases1999–2010
- Screen For Synthetic Lethality In Mycobacterium TuberculosisNational Institute Of Mental Health2008
- Mycobacterium Tuberculosis Survival Regulatory GenesNational Institute Of Allergy And Infectious Diseases2007–2008
- Toolbox For Tuberculosis Drug DevelopmentNational Institute Of Allergy And Infectious Diseases2003–2007
- M. TB. Survival Regulatory GenesNational Institute Of Allergy And Infectious Diseases2004–2006
- Multidisciplinary Training In TuberculosisNational Institute Of Allergy And Infectious Diseases2001–2005
- Cell Division Control And Virulence In MycobacteriaNational Institute Of Allergy And Infectious Diseases2001–2005
- Latency And Reactivation TuberculosisNational Heart, Lung, And Blood Institute2002
- Rational Drug Discovery For MAC And M TBNational Institute Of Allergy And Infectious Diseases1998–2002
- M TB Survival Regulatory GenesNational Institute Of Allergy And Infectious Diseases1997–2001
- Search For Genetic Regulators Of Latency In M TBNational Institute Of Allergy And Infectious Diseases1994–1998
